FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Knud Bendix

Research Profile

Procedures

Chemicals & Drugs

Disorders

Living Beings

Concepts & Ideas

Cohort Studies

Physiology

Drug Resistance, Neoplasm

Co-author Network

Publications

TOP 3
Maja Ø Vase; Patrick Bastien; Knud Bendix; Mariann Christensen; Ylva K Hellberg; Carsten S Larsen; Eskild Petersen; Christophe Ravel; Henrik Schaumburg; Francesco d'Amore
Development of splenic marginal zone lymphoma in a HIV-negative patient with visceral leishmaniasis.
Peter Kamper; Maja Ludvigsen; Michael Boe Møller; Jens R Nyengaard; Gabriel A Rabinovich; Knud Bendix; Stephen Hamilton-Dutoit; Bent Honoré; Francesco d'Amore
Proteomic analysis identifies galectin-1 as a predictive biomarker for relapsed/refractory disease in classical Hodgkin lymphoma.
Maciej Bogdan Maniecki; Knud Bendix; Henrik Hasle; Holger Jon Møller
Is hepatotoxicity in patients treated with gemtuzumabozogamicin due to specific targeting of hepatocytes?

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Knud Bendix (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Maja Ø Vase; Patrick Bastien; Knud Bendix; Mariann Christensen; Ylva K Hellberg; Carsten S Larsen; Eskild Petersen; Christophe Ravel; Henrik Schaumburg; Francesco d'Amore
Development of splenic marginal zone lymphoma in a HIV-negative patient with visceral leishmaniasis.
Acta haematologica 2012;128(1):20-2.
2011: Peter Kamper; Maja Ludvigsen; Michael Boe Møller; Jens R Nyengaard; Gabriel A Rabinovich; Knud Bendix; Stephen Hamilton-Dutoit; Bent Honoré; Francesco d'Amore
Proteomic analysis identifies galectin-1 as a predictive biomarker for relapsed/refractory disease in classical Hodgkin lymphoma.
Blood 2011;117(24):6638-49.
2011: Maciej Bogdan Maniecki; Knud Bendix; Henrik Hasle; Holger Jon Møller
Is hepatotoxicity in patients treated with gemtuzumabozogamicin due to specific targeting of hepatocytes?
Leukemia research 2011;35(6):e84-6.
2011: Michael B Pedersen; Y Zhao; M C Arendrup; Knud Bendix; M Bojsen-Møller; Ingolf Mølle; F D'Amore
Co-existence of cerebral infection with Rhinocladiella mackenziei and primary central nervous system lymphoma in a HIV-negative patient.
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 2011;119(3):221-3.
2011: Peter Kamper; Knud Bendix; Stephen Hamilton-Dutoit; Bent Honoré; Jens R Nyengaard; Francesco d'Amore
Tumor-infiltrating macrophages correlate with adverse prognosis and Epstein-Barr virus status in classical Hodgkin's lymphoma.
Haematologica 2011;96(2):269-76.
2010: Lene Sofie Granfeldt Ostgård; Eigil Kjeldsen; Mette S Holm; Peter De Nully Brown; Bjarne Bach Pedersen; Knud Bendix; Preben Johansen; Jørgen S Kristensen; Jan Maxwell Nørgaard
Reasons for treating secondary AML as de novo AML.
European journal of haematology 2010;85(3):217-26.
2009: Judit M Jørgensen; Flemming B Sørensen; Knud Bendix; Johan Lanng Nielsen; Anette Funder; Marika J Karkkainen; Tapio Tainola; Annette B Sørensen; Finn S Pedersen; Francesco D'Amore
Expression level, tissue distribution pattern, and prognostic impact of vascular endothelial growth factors VEGF and VEGF-C and their receptors Flt-1, KDR, and Flt-4 in different subtypes of non-Hodgkin lymphomas.
Leukemia & lymphoma 2009;50(10):1647-60.
2007: J M Jørgensen; F B Sørensen; Knud Bendix; Johan Lanng Nielsen; M L Olsen; A M D Funder; F d'Amore
Angiogenesis in non-Hodgkin's lymphoma: clinico-pathological correlations and prognostic significance in specific subtypes.
Leukemia & lymphoma 2007;48(3):584-95.
2007: Charlotte Guldborg Nyvold; Knud Bendix; Margrethe Brandsborg; Stanislaw Pulczynski; Trine Silkjaer; Peter Hokland
Multiplex PCR for the detection of BCL-1/IGH and BCL-2/IGH gene rearrangements--clinical validation in a prospective study of blood and bone marrow in 258 patients with or suspected of non-Hodgkin's lymphoma.
Acta oncologica (Stockholm, Sweden) 2007;46(1):21-30.
2005: Peter M Kamper; Eigil Kjeldsen; Niels Clausen; Knud Bendix; Stephen Hamilton-Dutoit; Francesco d'Amore
Epstein-Barr virus-associated familial Hodgkin lymphoma: paediatric onset in three of five siblings.
British journal of haematology 2005;129(5):615-7.
2001: Jan Maxwell Nørgaard; Lene Hyldahl Olesen; Gitte Olesen; K Meyer; Jørgen S Kristensen; Knud Bendix; Bent Pedersen; Eigil Kjeldsen; Peter Hokland
FAB M4 and high CD14 surface expression is associated with high cellular resistance to Ara-C and daunorubicin: implications for clinical outcome in acute myeloid leukaemia.
European journal of haematology 2001;67(4):221-9.
2001: Lise Mette Gjerdrum; I Lielpetere; L M Rasmussen; Knud Bendix; Stephen Hamilton-Dutoit
Laser-assisted microdissection of membrane-mounted paraffin sections for polymerase chain reaction analysis: identification of cell populations using immunohistochemistry and in situ hybridization.
The Journal of molecular diagnostics : JMD 2001;3(3):105-10.
1999: Jan Maxwell Nørgaard; P D Jensen; Knud Bendix; Niels Clausen; Torben Palshof
Relevance of in vitro leukaemia cell survival to short- and long term clinical outcome in AML.
Leukemia & lymphoma 1999;32(3-4):327-37.
1998: Peter Hokland; Bent Pedersen; Knud Bendix; J E Koch; N Pallisgaard
[Multidisciplinary diagnostics in acute leukemia].
Ugeskrift for laeger 1998;160(38):5473-8.